Jasper Therapeutics Stock (NASDAQ: JSPR)
|Day Range0.73 - 0.86||52 Wk Range0.78 - 8.12||Open / Close0.86 / 0.79||Float / Outstanding19.3M / 36.7M|
|Vol / Avg.192.1K / 64.7K||Mkt Cap28.9M||P/E-||50d Avg. Price1.76|
|Div / Yield-||Payout Ratio-||Total Float19.3M||EPS-0.29|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Jasper Therapeutics (NASDAQ: JSPR) through any online brokerage.
The latest price target for Jasper Therapeutics (NASDAQ: JSPR) was reported by Credit Suisse on Wednesday, July 13, 2022. The analyst firm set a price target for 8.00 expecting JSPR to rise to within 12 months (a possible 913.81% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $0.7891 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.